Medicinal Chemistry : Principles and Practice (2ND)

個数:

Medicinal Chemistry : Principles and Practice (2ND)

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合、分割発送となる場合がございます。
    3. 美品のご指定は承りかねます。
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 472 p.
  • 言語 ENG
  • 商品コード 9780854046317
  • DDC分類 615.19

Full Description

This book introduces the principles and practices of modern medicinal chemistry and covers all aspects of drug discovery from the initial lead to final development. It teaches how to convert a lead compound into a potential drug and provides recent case histories as examples of successes. Medicinal Chemistry is unique in dealing with the subject in such a practical way and is the only book currently available to bring together all areas of the subject in one volume. This breadth of coverage is supplemented by references to specialist monographs and reviews, where the reader can find more detail on specific topics of interest if required. Medicinal Chemistry is essential reading for students studying medicinal chemistry, as it provides a grounding in all the required disciplines and subjects. It will also be of great interest to chemists, biochemists and pharmacologists either already working in or contemplating a career in the pharmaceutical and allied industries.

Contents

An Introduction to Drug-Receptor Interactions; Signal Transduction and Second Messengers; Enzyme Inhibitors; The Biological Evaluation of New Compounds; Pharmacokinetics; Drug Metabolism; Physicochemical Properties and Drug Design; Quantitative Structure-Activity Relationships; Considerations for the Use of Computational Chemistry Techniques by Medicinal Chemists; `Patent Medicine'; Molecular Biology - A New Route to Drug Discovery; Devising a Research Strategy; Past Approaches to Discovering New Drugs as Medicines; Bioisosteres, Conformational Restriction, and Pro-drugs: Approaches to Lead Optimisation - Case History: An Example of a Conformational Restriction Approach; The Design and Synthesis of Selective Protein Kinase C Inhibitors; Discovery of 1069C - A Novel Synthetic Antitumour Agent with Low Cross-resistance Potential; The Design and Biological Properties of `Dipeptoid' Antagonists; Migraine Therapy - From Serotonin to Sumatriptan; Drug Development; Appendices; Subject Index.